OBJECTIVE: We examined the relationship between habitual daily physical activity and measures of glucose tolerance, insulin sensitivity, and β-cell responses in adults with impaired glucose tolerance (IGT) or drug-naive, recently diagnosed type 2 diabetes. RESEARCH DESIGN AND METHODS: Participants included 230 adults (mean ± SD age 54.5 ± 8.5 years, BMI 35 ± 5.5 kg/m2; 42.6% women) who underwent a 3-h oral glucose tolerance test (OGTT) and hyperglycemic clamp. Wrist accelerometers worn for 7 consecutive days measured total physical activity counts (TAC) (daily mean 233,460 [∼50th percentile for age]). We evaluated whether TAC was associated with fasting plasma glucose, OGTT 2-h plasma glucose or glucose incremental area under the curve (G-iAUC), hyperglycemic clamp measures of insulin sensitivity (steady-state glucose infusion rate/insulin [M/I]) and β-cell responses (acute C-peptide response to glucose, steady-state C-peptide, and maximal β-cell response), and OGTT C-peptide index (ΔC-peptide0-30/Δglucose0-30). RESULTS: After adjustments for confounders, there was no association of TAC with fasting plasma glucose, 2-h glucose, or G-iAUC. Higher TAC was associated with higher insulin sensitivity (M/I). After adjusting for M/I, higher TAC was not associated with measures of β-cell response. CONCLUSIONS: In adults with IGT or drug-naive, recently diagnosed type 2 diabetes, higher levels of habitual physical activity are associated with higher insulin sensitivity. Further studies are needed to understand why higher levels of physical activity are not associated with better β-cell response.
RCT Entities:
OBJECTIVE: We examined the relationship between habitual daily physical activity and measures of glucose tolerance, insulin sensitivity, and β-cell responses in adults with impaired glucose tolerance (IGT) or drug-naive, recently diagnosed type 2 diabetes. RESEARCH DESIGN AND METHODS: Participants included 230 adults (mean ± SD age 54.5 ± 8.5 years, BMI 35 ± 5.5 kg/m2; 42.6% women) who underwent a 3-h oral glucose tolerance test (OGTT) and hyperglycemic clamp. Wrist accelerometers worn for 7 consecutive days measured total physical activity counts (TAC) (daily mean 233,460 [∼50th percentile for age]). We evaluated whether TAC was associated with fasting plasma glucose, OGTT 2-h plasma glucose or glucose incremental area under the curve (G-iAUC), hyperglycemic clamp measures of insulin sensitivity (steady-state glucose infusion rate/insulin [M/I]) and β-cell responses (acute C-peptide response to glucose, steady-state C-peptide, and maximal β-cell response), and OGTT C-peptide index (ΔC-peptide0-30/Δglucose0-30). RESULTS: After adjustments for confounders, there was no association of TAC with fasting plasma glucose, 2-h glucose, or G-iAUC. Higher TAC was associated with higher insulin sensitivity (M/I). After adjusting for M/I, higher TAC was not associated with measures of β-cell response. CONCLUSIONS: In adults with IGT or drug-naive, recently diagnosed type 2 diabetes, higher levels of habitual physical activity are associated with higher insulin sensitivity. Further studies are needed to understand why higher levels of physical activity are not associated with better β-cell response.
Authors: S E Kahn; V G Larson; R S Schwartz; J C Beard; K C Cain; G W Fellingham; J R Stratton; M D Cerqueira; I B Abrass Journal: J Clin Endocrinol Metab Date: 1992-06 Impact factor: 5.958
Authors: William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan Journal: N Engl J Med Date: 2002-02-07 Impact factor: 91.245
Authors: Roberto A Rabinovich; Zafeiris Louvaris; Yogini Raste; Daniel Langer; Hans Van Remoortel; Santiago Giavedoni; Chris Burtin; Eloisa M G Regueiro; Ioannis Vogiatzis; Nicholas S Hopkinson; Michael I Polkey; Frederick J Wilson; William Macnee; Klaas R Westerterp; Thierry Troosters Journal: Eur Respir J Date: 2013-02-08 Impact factor: 16.671
Authors: M Dauriz; E Bacchi; L Boselli; L Santi; C Negri; M Trombetta; R C Bonadonna; E Bonora; P Moghetti Journal: Nutr Metab Cardiovasc Dis Date: 2018-01-09 Impact factor: 4.222
Authors: William R Boyer; Dana L Wolff-Hughes; David R Bassett; James R Churilla; Eugene C Fitzhugh Journal: Prev Chronic Dis Date: 2016-10-20 Impact factor: 2.830
Authors: Babak Mokhlesi; Ashley H Tjaden; Karla A Temple; Sharon L Edelstein; Susan Sam; Kristen J Nadeau; Tamara S Hannon; Shalini Manchanda; Kieren J Mather; Steven E Kahn; David A Ehrmann; Eve Van Cauter Journal: Diabetes Care Date: 2021-02-05 Impact factor: 19.112